Experimental drugs for fallopian cancer: promising agents in the clinical trials and key stumbling blocks for researchers
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2022.2160313
Abstract: ABSTRACT Introduction Fallopian tube carcinoma (FC) as a single entity is a rare disease. Although its diagnosis is increasing thanks to the widespread use of prophylactic salpingectomy, there are no clinical trials exclusively designed for… read more here.
Keywords: clinical trials; cancer promising; drugs fallopian; fallopian cancer ... See more keywords
CD70 and PD‐L1 in anaplastic thyroid cancer – promising targets for immunotherapy
Sign Up to like & getrecommendations! Published in 2017 at "Histopathology"
DOI: 10.1111/his.13230
Abstract: During recent years, immune checkpoint inhibition has proved to be effective in several solid malignancies. The aim of this study was to identify novel targets for immunotherapy in anaplastic thyroid cancer by analysis of the… read more here.
Keywords: anaplastic thyroid; targets immunotherapy; thyroid cancer; cd70 anaplastic ... See more keywords
Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Gastrointestinal Oncology"
DOI: 10.4251/wjgo.v14.i10.1903
Abstract: Currently, 15 randomized controlled trials (RCTs) have been designed to investigate whether neoadjuvant therapy (NAT) benefits patients with resectable pancreatic adenocarcinoma (R-PA) compared to surgery alone. Five of them have acquired results so far; however,… read more here.
Keywords: neoadjuvant therapy; resectable pancreatic; cancer promising; pancreatic cancer ... See more keywords